-
Cytomegalovirus Infection After Solid Organ Transplantation: New Guidance, Old Questions
CME The relative advantages of CMV prophylaxis and preemptive therapy in transplant recipients are discussed in the context of new guidelines.
Medscape Education Transplantation , June 2011
-
Pulmonary Veno-occlusive Disease: Clinical Management and Treatments
What are the best practices for the diagnosis and management of pulmonary veno-occlusive disease? The current review addresses this issue.
Expert Review of Respiratory Medicine, April 2011
-
Management of CMV Infection After Thoracic Organ Transplantation
Review current information on CMV and explore the best ways to ensure optimal patient outcomes.
August 2010
-
Cystic Fibrosis: Diagnosis and Treatment of From Childhood to Adulthood
As the life expectancy of patients with CF increases, best practices in transitioning them from pediatric to adult care remain ill defined. Explore these 2 unique cases in CF management.
Medscape Education Pulmonary Medicine, June 2010
-
Heart Transplants and Skin Cancer
Heart-transplant recipients have cumulative skin-cancer incidence rates of over 20% at 5 years and almost 50% at 15 years posttransplant and chances of a squamous-cell cancer within 7 years.
Heartwire CME, January 2010
-
Beyond Pharmacology in Advanced Heart Failure: The Efficacy of Mechanical Circulatory Support
Join Drs. Peter Eckman, Christophe Leclercq, Mariell Jessup, Leslie Miller, Joseph Rogers, and Donald Haas as they discuss the management of heart failure patients and late-breaking results from the HeartMate II Destination Therapy Clinical Trial.
Medscape Education Cardiology, November 2009
-
Prevention of Late-Onset CMV Disease in Solid Organ Transplant Recipients
The results of the IMPACT study provide us with a new evidence-guided option for prevention of late-onset cytomegalovirus disease solid organ transplant recipients.
Medscape Education Transplantation , July 2009
-
Shortness of Breath in a 62-Year-Old Man 26 Months After Cardiac Transplantation
A 62-year-old man presents with a 3-month history of dyspnea, fatigue, and weight loss. He had a heart transplant 26 months ago, with follow-up immunosuppression therapy. What is the diagnosis?
Medscape CME Case Presentations, March 2009
-
Pulmonary Arterial Hypertension Guidelines
Drs. Nathan, Frost, and McLaughlin discuss the 2006 ACCP clinical practice guidelines on medical therapy for PAH and beyond, including new therapies on the market since their release.
Medscape Pulmonary Medicine, June 2008
-
Guidelines for Pulmonary Arterial Hypertension
Drs. Nathan, Frost, and McLaughlin discuss the 2006 ACCP clinical practice guidelines on medical therapy for PAH and beyond, including new therapies on the market since their release.
Medscape Pulmonary Medicine, June 2008
-
Sarcoidosis and Pulmonary Hypertension
A review of the current data on sarcoidosis and pulmonary hypertension.
Medscape Pulmonary Medicine, February 2008
-
Care of the Transplant Patient
A discussion of the perioperative and postoperative care of patients undergoing organ transplant.
Medscape Pulmonary Medicine, January 2008
-
Highlights of the United States and Canadian Academy of Pathology 2007 Annual Meeting
Drs. Andrea Arrossi and Carol Farver discuss the pulmonary pathology of transplantation in highlights from the USCAP 2007 Annual Meeting.
Medscape Pathology, November 2007
-
Treating Pulmonary Fibrosis and Pulmonary Hypertension
What is the first-line drug therapy for patients with pulmonary hypertension caused by pulmonary fibrosis/interstitial lung disease?
Medscape Education Pulmonary Medicine, May 2007
-
Pulmonary Hypertension in Congenital Heart Disease
An update on the diagnosis and treatment of Eisenmenger's syndrome.
Medscape Pulmonary Medicine, February 2007
-
Evolving Complexities and Therapeutic Strategies in PAH
What are the differences between selective and dual endothelin receptor antagonists? This review looks at the evolving complexities in selecting a treatment for PAH.
Medscape Cardiology, November 2006
-
The Classification of Pulmonary Arterial Hypertension
Why does the literature sometimes refer to WHO functional class and sometimes to NYHA functional class? What is the difference?
Medscape Education Pulmonary Medicine, September 2006
-
Therapeutic Compliance Posttransplantation -- A Nurse's Perspective
Fourth in a series presented by the DHHS/NIH/NIAID. Discuss the current language used in describing transplantation compliance, evaluate the short- and long-term impact of noncompliance on the transplant recipient, and evaluate methods of determining, evaluating, and addressing compliance issues.
September 2005
-
Managing Physical Side Effects of Immunosuppression
Considering the high prevalence of and myriad of risk factors for nonadherence, it seems wise to assume that every transplant patient, especially the adolescent, is at risk for nonadherence.
Medscape Transplantation, August 2005
-
Early Diagnosis and Treatment of Pulmonary Arterial Hypertension
An overview of diagnosis and treatment strategies for pulmonary arterial hypertension
Medscape Pulmonary Medicine, June 2005
